SIMPLEX TRADING, LLC - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 229 filers reported holding EDITAS MEDICINE INC in Q4 2019. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$198
+90.4%
25,507
+101.5%
0.00%
Q2 2023$104
+173.7%
12,656
+139.0%
0.00%
Q1 2023$38
-100.0%
5,296
-87.2%
0.00%
-100.0%
Q3 2022$505,000
-33.9%
41,268
+43.3%
0.00%0.0%
Q4 2021$764,000
-85.9%
28,796
-70.0%
0.00%
-80.0%
Q3 2021$5,418,000
+0.2%
95,876
+0.4%
0.01%0.0%
Q2 2021$5,406,00095,453
+21.4%
0.01%
Q1 2021$0
-100.0%
78,648
+1068.6%
0.00%
Q3 2020$188,000
-60.6%
6,730
-58.3%
0.00%
-100.0%
Q2 2020$477,000
-70.9%
16,155
-80.4%
0.00%
-66.7%
Q1 2020$1,637,000
+139.7%
82,584
+257.6%
0.00%
+200.0%
Q4 2019$683,000
+658.9%
23,095
+482.5%
0.00%
Q3 2019$90,000
-78.5%
3,965
-76.9%
0.00%
-100.0%
Q1 2019$419,000
+1063.9%
17,148
+965.1%
0.00%
Q4 2018$36,000
-92.0%
1,610
-88.6%
0.00%
-100.0%
Q3 2018$448,000
-49.7%
14,107
-43.3%
0.00%
-66.7%
Q2 2018$891,000
-13.4%
24,882
-19.9%
0.00%
-93.3%
Q1 2018$1,029,000
+181.9%
31,060
+161.3%
0.04%
+181.2%
Q4 2017$365,000
+51.5%
11,885
+18.1%
0.02%
+60.0%
Q3 2017$241,000
-66.5%
10,063
-76.6%
0.01%
-67.7%
Q2 2017$720,000
+198.8%
42,930
+296.7%
0.03%
+210.0%
Q1 2017$241,000
+119.1%
10,822
+59.5%
0.01%
+42.9%
Q4 2016$110,000
-4.3%
6,786
-21.0%
0.01%
-12.5%
Q3 2016$115,0008,5860.01%
Other shareholders
EDITAS MEDICINE INC shareholders Q4 2019
NameSharesValueWeighting ↓
Deep Track Capital, LP 7,101,935$55,395,0932.14%
Green Alpha Advisors, LLC 77,188$602,0660.46%
Woodline Partners LP 3,259,710$25,425,7380.30%
TANG CAPITAL MANAGEMENT LLC 200,000$1,560,0000.22%
Spectrum Planning & Advisory Services Inc. 14,038$109,4960.17%
PDT Partners, LLC 156,515$1,220,8170.15%
CALTON & ASSOCIATES, INC. 13,420$104,6760.15%
Corton Capital Inc. 29,365$229,0470.12%
CAXTON ASSOCIATES LP 61,223$477,5390.07%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 119,287$930,4390.06%
View complete list of EDITAS MEDICINE INC shareholders